Status:
UNKNOWN
Switching From Ticagrelor to Prasugrel in Patients With Acute Coronary Syndrome
Lead Sponsor:
Vastra Gotaland Region
Collaborating Sponsors:
Region Skane
Region Halland
Conditions:
Acute Coronary Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
This study proposes to conduct the switch from ticagrelor to prasugrel in an organized stepwise manner, to allow for the evaluation of the relative efficacy of prasugrel versus ticagrelor using a step...
Detailed Description
The SWITCH SWEDEHEART trial is a prospective, multicenter, open-label, cross-sectional, stepped wedge cluster randomized clinical study, in which administrative regions in Sweden will constitute the c...
Eligibility Criteria
Inclusion
- Patients hospitalized for Acute coronary syndrome, as defined by the European Society of Cardiology, at any hospital participating in the study, and included in the SWEDEHEART registry during index hospitalization
- Age ≥ 18 years.
Exclusion
- Patients on oral anticoagulation therapy
- Previous stroke
Key Trial Info
Start Date :
February 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
16000 Patients enrolled
Trial Details
Trial ID
NCT05183178
Start Date
February 1 2022
End Date
December 31 2025
Last Update
March 17 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. Cardiology, Skånes universitetssjukhus
Lund, Sweden, 22185